Dystrophic pathology in the intrinsic and extrinsic laryngeal muscles in the mdx mouse

Journal of Otolaryngology - Head and Neck Surgery

Volumn 38, Issue 3, 2009, Pages 323-336

  Smythe, Gayle M ^a  

^a CHARLES STURT UNIVERSITY   (Australia)

Author keywords

Degeneration; Duchenne muscular dystrophy; Intrinsic laryngeal; mdx; Skeletal muscle

Indexed keywords

BETA DYSTROGLYCAN; CAVEOLIN 3; DYSTROPHIN; EVANS BLUE; UTROPHIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIAPHRAGM MUSCLE; DUCHENNE MUSCULAR DYSTROPHY; DYSTROPHIN DEFICIENCY; EXTRAOCULAR MUSCLE; HINDLIMB; HISTOPATHOLOGY; IMMUNOFLUORESCENCE; LARYNX MUSCLE; MOUSE; MUSCLE CELL; MUSCLE DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; TIBIALIS ANTERIOR MUSCLE; TISSUE NECROSIS; UPREGULATION; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

ANIMALS; DISEASE MODELS, ANIMAL; LARYNGEAL MUSCLES; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MUSCULAR DYSTROPHY, DUCHENNE; NECROSIS;

EID: 67049160572     PISSN: 19160216     EISSN: None     Source Type: Journal    
DOI: 10.2310/7070.2009.080102     Document Type: Article

References (58)

1. Hoffman EP, Brown RH, Kunkel LM. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 1987;51: 919-928
2. Ervasti JM, Campbell KP. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J Cell Biol 1993;122:809-823
3. Doyle DD, Goings G, Upshaw-Earley J, et al. Dystrophin associates with caveolae of rat cardiac myocytes. Circ Res 2000;87:480-488
4. Dupont-Versteegden EE, McCarter RJ. Differential expression of muscular dystrophy in diaphragm versus hindlimb muscles of mdx mice. Muscle Nerve 1992;15:1105-1110
5. Louboutin JP, Fichter-Gagnepain V, Thaon E, Fardeau M. Morphometric analysis of mdx diaphragm muscle fibres. Comparison with hindlimb muscles. Neuromuscul Disord 1993; 3:463-469
6. Andrade FH, Porter JD, Kaminski HJ. Eye muscle sparing by the muscular dystrophies: lessons to be learned? Microsc Res Tech 2000;48:192-203.
7. Kaminski HJ, al-Hakim M, Leigh RJ, et al. Extraocular muscles are spared in advanced Duchenne dystrophy. Ann Neurol 1992;32: 586-588
8. Khurana TS, Prendergast RA, Alameddine HS, et al. Absence of extraocular muscle pathology in Duchenne's muscular dystrophy: role for calcium homeostasis in extraocular muscle sparing. J Exp Med 1995;182:467-475
9. Porter JD, Merriam AP, Khanna S, et al. Constitutive properties, not molecular adaptations, mediate extraocular muscle sparing in dystrophic mdx mice. FASEB J 2003;17:893-895
10. Manolides L, Baloyannis S. Histological and ultrastructural findings in the vocal muscles of patients suffering from muscular dystrophies. Arch Otorhinolaryngol 1981;230:181-188
11. Marques MJ, Ferretti R, Vomero VU, et al. Intrinsic laryngeal muscles are spared from myonecrosis in the mdx mouse model of Duchenne muscular dystrophy. Muscle Nerve 2007;35:349-353
12. Billard C, Gillet P, Barthez M, et al. Reading ability and processing in Duchenne muscular dystrophy and spinal muscular atrophy. Dev Med Child Neurol 1998;40:12-20.
13. Mohammed K, Appleton R, Nicolaides P. Delayed diagnosis of Duchenne muscular dystrophy. Eur J Paedatr Neurol 2000;4: 219-223
14. Parsons EP, Clarke AJ, Bradley DM. Developmental progress in Duchenne muscular dystrophy: lessons for earlier detection. Eur J Paediatr Neurol 2004;8:145-153
15. Wicksell RK, Kihlgren M, Melin L, Eeg-Olofsson O. Specific cognitive deficits are common in children with Duchenne muscular dystrophy. Dev Med Child Neurol 2004;46:154-159
16. Attal P, Lambert F, Marchand-Adam S, et al. Severe mechanical dysfunction in pharyngeal muscle from adult mdx mice. Am J Respir Crit Care Med 2000;162:78-281.
17. Baddeley A, Vedel Jensen EB. Stereology for statisticians. Boca Raton, USA: Chapman & Hall/CRC; 2005.
18. Hoh JFY. Laryngeal muscle fibre types. Acta Physiol Scand 2005; 183:133-149
19. Shinners MJ, Goding GS, McLoon LK. Effect of recurrent laryngeal nerve section on the laryngeal muscles of adult rabbits. Otolaryngol Head Neck Surg 2006;134:413-418
20. Shaw GY, Searle JP, Hoover LA. Diagnosis and treatment of unilateral cricothyroid muscle paralysis with a modified Isshiki type 4 thyroplasty. Otolaryngol Head Neck Surg 1995;113:679-688
21. Kuna ST, Smickley JS, Vanoye CR, McMillan TH. Cricothyroid muscle activity during sleep in normal adult humans. J Appl Physiol 1994;76:2326-2332
22. Bartlett D. Respiratory functions of the larynx. Physiol Rev 1989; 69:33-57.
23. Wheatley JR, Brancatisano A, Engel LA. Respiratory-related activity of cricothyroid muscle in awake normal humans. J Appl Physiol 1991;70:2226-2232
24. Schramm CM. Current concepts of respiratory complications of neuromuscular disease in children. Curr Opin Pediatr 2000;12: 203-207
25. Pane M, Vasta I, Messina S, et al. Feeding problems and weight gain in Duchenne muscular dystrophy. Eur J Paediatr Neurol 2006; 10:231-236
26. Sahashi K, Ibi T, Suoh H, et al. Immunostaining of dystrophin and utrophin in skeletal muscle of dystrophinopathies. Intern Med 1994;33:277-283
27. Thanh LT, Nguyen TM, Helliwell TR, Morris GE. Characterization of revertant muscle fibers in Duchenne muscular dystrophy, using exon-specific monoclonal antibodies against dystrophin. Am J Hum Genet 1995;56:725-731
28. Wilton SD, Dye DE, Blechynden LM, Laing NG. Revertant fibres: a possible genetic therapy for Duchenne muscular dystrophy? Neuromuscul Disord 1997;7:329-335
29. Matsumura K, Tome FMS, Ionasescu V, et al. Deficiency of dystrophin-associated proteins in Duchenne muscular dystrophy patients lacking COOH-terminal domains of dystrophin. J Clin Invest 1993;92:866-871
30. Ohlendieck K, Matsumura K, Ionasescu VV, et al. Duchenne muscular dystrophy: deficiency of dystrophin-associated proteins in the sarcolemma. Neurology 1993;43:795-800.
31. Dowling P, Culligan K, Ohlendieck K. Distal mdx muscle groups exhibiting up-regulation of utrophin and rescue of dystrophin-associated glycoproteins exemplify a protected phenotype in muscular dystrophy. Naturwissenschaften 2002;89:75-78
32. Dowling P, Lohan J, Ohlendieck K. Comparative analysis of Dp427-deficient mdx tissues shows that the milder dystrophic phenotype of extraocular and toe muscle fibres is associated with a persistent expression of β-dystroglycan. Eur J Cell Biol 2003;82: 222-230
33. Law DJ, Allen DL, Tidball JG. Talin, vinculin and DRP (utrophin) concentrations are increased at mdx myotendinous junctions following onset of necrosis. J Cell Sci 1994;107:1477-1483
34. Matsumura K, Ervasti JM, Ohlendieck K, et al. Association of dystrophin-related protein with dystrophin-associated proteins in mdx mouse muscle. Nature 1992;360:588-591
35. Nguyen M, Ellis JM, Love DR, et al. Localization of the DMDL gene-encoded dystrophin-related protein using a panel of nineteen monoclonal antibodies: presence at neuromuscular junctions, in the sarcolemma of dystrophic skeletal muscle, in vascular and other smooth muscles, and in proliferating brain cell lines. J Cell Biol 1991;115:1695-1700
36. Porter JD, Rafael JA, Ragusa RJ, et al. The sparing of extraocular muscle in dystrophinopathy is lost in mice lacking utrophin and dystrophin. J Cell Sci 1998;111:1801-1811
37. Tinsley JM, Potter AC, Phelps SR, et al. Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene. Nature 1996;384:349-353
38. Tinsley J, Deconcinck N, Fisher R, et al. Expression of full-length utrophin prevents muscular dystrophy in mdx mice. Nat Med 1998;4:1441-1444
39. Vainzof M, Passos-Bueno MR, Man N, Zatz M. Absence of correlation between utrophin localization and quantity and clinical severity in Duchenne/Becker dystrophies. Am J Med Genet 1995; 58:305-309
40. Yamane A, Akutsu S, Diekwisch TGH, Matsuda R. Satellite cells and utrophin are not directly correlated with the degree of muscle damage in mdx mice. Am J Physiol 2005;289:C42-8.
41. Crosbie RH, Yamada H, Venzke DP, et al. Caveolin-3 is not an integral component of the dystrophin glycoprotein complex. FEBS Lett 1998;427:279-282
42. Sotgia F, Lee JK, Das K, et al. Caveolin-3 directly interacts with the C-terminal tail of beta-dystroglycan. Identification of a central WW-like domain within caveolin family members. J Biol Chem 2000;275:38048-38058
43. Garcia-Cardena G, Martasek P, Masters BS, et al. Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. J Biol Chem 1997;272:25437-25440
44. Carozzi AJ, Roy S, Morrow IC, et al. Inhibition of lipid raft-dependent signaling by a dystrophy-associated mutant of caveolin- 3. J Biol Chem 2002;277:17944-17949
45. Galbiati F, Volonte D, Engelman JA, et al. Targeted downregulation of caveolin-3 is sufficient to inhibit myotube formation in differentiating C2C12 myoblasts. J Biol Chem 1999;274:30315-30321
46. Ha H, Pak Y. Modulation of the caveolin-3 and Akt status in caveolae by insulin resistance in H9c2 cardiomyoblasts. Exp Mol Med 2005;37:169-178
47. Meacci E, Donati C, Cencetti F, et al. Receptor-activated phospholipase D is present in caveolin-3-enriched light membranes of C2C12 myotubes. FEBS Lett 2000;473:10-14
48. Scherer PE, Lisanti MP. Association of phosphofructokinase-M with caveolin-3 in differentiated skeletal myotubes. J Biol Chem 1997;272:20698-20705
49. Smythe GM, Eby JC, Disatnik MH, Rando TA. A caveolin-3 mutant that causes limb girdle muscular dystrophy type 1C disrupts Src localization and activity and induces apoptosis in skeletal myotubes. J Cell Sci 2003;116:4739-4749
50. Smythe GM, Rando TA. Altered caveolin-3 expression disrupts PI(3) kinase signaling leading to death of cultured muscle cells. Exp Cell Res 2006;312:2816-2825
51. Sotgia F, Razani B, Bonuccelli G, et al. Intracellular retention of glycosylphosphatidyl inositol-linked proteins in caveolin-deficient cells. Mol Cell Biol 2002;22:3905-3926
52. Sotgia F, Bonuccelli G, Minetti C, et al. Phosphofructokinase muscle-specific isoform requires caveolin-3 expression for plasma membrane recruitment and caveolar targeting: implications for the pathogenesis of caveolin-related muscle diseases. Am J Pathol 2003; 163:2619-2634
53. Venema VJ, Ju H, Zou R, Venema RC. Interaction of neuronal nitric-oxide synthase with caveolin-3 in skeletal muscle. Identification of a novel caveolin scaffolding/inhibitory domain. J Biol Chem 1997;272:28187-28190
54. Volonte D, Peoples AJ, Galbiati F. Modulation of myoblast fusion by caveolin-3 in dystrophic skeletal muscle cells: implications for Duchenne muscular dystrophy and limb-girdle muscular dystrophy- 1C. Mol Biol Cell 2003;14:4075-4088
55. Vaghy PL, Fang J, Wu W, Vaghy LP. Increased caveolin-3 levels in mdx mouse muscles. FEBS Lett 1998;431:125-127
56. Repetto S, Bado M, Broda P, et al. Increased number of caveolae and caveolin-3 overexpression in Duchenne muscular dystrophy. Biochem Biophys Res Commun 1999;261:547-550
57. Galbiati F, Volonte D, Chu JB, et al. Transgenic overexpression of caveolin-3 in skeletal muscle fibers induces a Duchenne-likemuscular dystrophy phenotype. Proc Natl Acad Sci U S A 2000;97:9689-9694
58. Peter AK, Crosbie RH. Hypertrophic response of Duchenne and limb-girdle muscular dystrophies is associated with activation of Akt pathway. Exp Cell Res 2006;312:2580-2591